1
|
Krex D, Klink B, Hartmann C, et al:
Long-term survival with glioblastoma multiforme. Brain.
130:2596–2606. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zhang W, Yan W, You G, et al: Genome-wide
DNA methylation profiling identifies ALDH1A3 promoter methylation
as a prognostic predictor in G-CIMP- primary glioblastoma. Cancer
Lett. 328:120–125. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Maegawa S, Yoshioka H, Itaba N, et al:
Epigenetic silencing of PEG3 gene expression in human glioma
cell lines. Mol Carcinog. 31:1–9. 2001.
|
4
|
van den Boom J, Wolter M, Kuick R, et al:
Characterization of gene expression profiles associated with glioma
progression using oligonucleotide-based microarray analysis and
real-time reverse transcription-polymerase chain reaction. Am J
Pathol. 163:1033–1043. 2003.
|
5
|
Hu Y, Pioli PD, Siegel E, et al: EFEMP1
suppresses malignant glioma growth and exerts its action within the
tumor extracellular compartment. Mol Cancer. 10:1232011. View Article : Google Scholar : PubMed/NCBI
|
6
|
He SM, Zhao ZW, Wang Y, et al: Reduced
expression of SMAD4 in gliomas correlates with progression and
survival of patients. J Exp Clin Cancer Res. 30:702011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Grønbaek K, Hother C and Jones PA:
Epigenetic changes in cancer. APMIS. 115:1039–1059. 2007.
|
8
|
Naderi EH, Findley HW, Ruud E, Blomhoff HK
and Naderi S: Activation of cAMP signaling inhibits DNA
damage-induced apoptosis in BCP-ALL cells through abrogation of p53
accumulation. Blood. 114:608–618. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Foltz G, Ryu GY, Yoon JG, et al:
Genome-wide analysis of epigenetic silencing identifies BEX1
and BEX2 as candidate tumor suppressor genes in malignant
glioma. Cancer Res. 66:6665–6674. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kim YJ, Yoon HY, Kim JS, et al:
HOXA9, ISL1 and ALDH1A3 methylation patterns
as prognostic markers for nonmuscle invasive bladder cancer:
array-based DNA methylation and expression profiling. Int J Cancer.
133:1135–1142. 2013. View Article : Google Scholar
|
11
|
Berdasco M, Ropero S, Setien F, et al:
Epigenetic inactivation of the Sotos overgrowth syndrome gene
histone methyltransferase NSD1 in human neuroblastoma and glioma.
Proc Natl Acad Sci USA. 106:21830–21835. 2009. View Article : Google Scholar : PubMed/NCBI
|
12
|
Jin SL, Ding SL and Lin SC:
Phosphodiesterase 4 and its inhibitors in inflammatory diseases.
Chang Gung Med J. 35:197–210. 2012.PubMed/NCBI
|
13
|
Beavo JA and Reifsnyder DH: Primary
sequence of cyclic nucleotide phosphodiesterase isozymes and the
design of selective inhibitors. Trends Pharmacol Sci. 11:150–155.
1990. View Article : Google Scholar : PubMed/NCBI
|
14
|
Conti M, Jin SL, Monaco L, Repaske DR and
Swinnen JV: Hormonal regulation of cyclic nucleotide
phosphodiesterases. Endocr Rev. 12:218–234. 1991. View Article : Google Scholar : PubMed/NCBI
|
15
|
Pérez-Torres S1, Miró X, Palacios JM,
Cortés R, Puigdoménech P and Mengod G: Phosphodiesterase type 4
isozymes expression in human brain examined by in situ
hybridization histochemistry and[3H]rolipram binding
autoradiography. Comparison with monkey and rat brain. J Chem
Neuroanat. 20:349–374. 2000.PubMed/NCBI
|
16
|
Naderi EH, Jochemsen AG, Blomhoff HK and
Naderi S: Activation of cAMP signaling interferes with
stress-induced p53 accumulation in ALL-derived cells by promoting
the interaction between p53 and HDM2. Neoplasia. 13:653–663.
2011.PubMed/NCBI
|
17
|
Li S, Yan C, Huang L, Qiu X, Wang Z and
Jiang T: Molecular prognostic factors of anaplastic
oligodendroglial tumors and its relationship: a single
institutional review of 77 patients from China. Neuro Oncol.
14:109–116. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Hill VK, Ricketts C, Bieche I, et al:
Genome-wide DNA methylation profiling of CpG islands in breast
cancer identifies novel genes associated with tumorigenicity.
Cancer Res. 71:2988–2999. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Cadieux B, Ching TT, VandenBerg SR and
Costello JF: Genome-wide hypomethylation in human glioblastomas
associated with specific copy number alteration,
methylenetetrahydrofolate reductase allele status, and increased
proliferation. Cancer Res. 66:8469–8476. 2006. View Article : Google Scholar
|
20
|
Owens RJ, Lumb S, Rees-Milton K, et al:
Molecular cloning and expression of a human phosphodiesterase 4C.
Cell Signal. 9:575–585. 1997. View Article : Google Scholar : PubMed/NCBI
|
21
|
Czernicki T, Zegarska J, Paczek L, et al:
Gene expression profile as a prognostic factor in high-grade
gliomas. Int J Oncol. 30:55–64. 2007.PubMed/NCBI
|
22
|
Freije WA, Castro-Vargas FE, Fang Z, et
al: Gene expression profiling of gliomas strongly predicts
survival. Cancer Res. 64:6503–6510. 2004. View Article : Google Scholar : PubMed/NCBI
|
23
|
Takahashi H and Kouno J: Gene expression
profiling of malignant gliomas by cDNA microarrays. Nihon Rinsho.
63(Suppl 9): 515–519. 2005.(In Japanese).
|
24
|
Yoshino A, Ogino A, Yachi K, et al: Gene
expression profiling predicts response to temozolomide in malignant
gliomas. Int J Oncol. 36:1367–1377. 2010. View Article : Google Scholar : PubMed/NCBI
|
25
|
Schatz P, Distler J, Berlin K and Schuster
M: Novel method for high throughput DNA methylation marker
evaluation using PNA-probe library hybridization and MALDI-TOF
detection. Nucleic Acids Res. 34:e592006. View Article : Google Scholar : PubMed/NCBI
|